Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Salutaris Medical Devices logo — Pioneering breakthroughs in treating eye diseases with preci...

Salutaris Medical Devices

Pioneering breakthroughs in treating eye diseases with precision radiotherapy.

Founded 2008 United States Tucson, United States 3 employees Series Unknown Total: $5.87M Biotechnology, Health Care +1

General Information

Company Name Salutaris Medical Devices
Founded Year 2008
Location United States Tucson, United States +1
Employees 3
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series Unknown
Social

Get notified when Salutaris Medical Devices moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Salutaris Medical Devices

Salutaris Medical Devices (SMD) is a clinical-stage radiotherapeutic company with a focus on pioneering breakthroughs in treating eye diseases with precision radiotherapy. The company has developed the BetaCurve™, a 510k-cleared device aimed at delivering the optimal dose of strontium-90 beta rays to treat challenging disease activity at the back of the eye. SMD's BetaCurve™ has the potential to aid millions of individuals suffering from various conditions, including Advanced Macular Degeneration (wet-AMD), Chronic Central Serous Chorioretinopathy (CCSR), Choroidal Hemangiomas, Early Small Ocular Melanoma, and Choroidal Dysplastic Nevi. Notably, wet-AMD is a leading cause of blindness in seniors globally, and the current treatments involving frequent lifetime eye injections are costly, unpleasant, and inadequate for many patients. The company's current focus is on treating the wet-AMD subtype that poorly responds to existing injection therapy, specifically PCV (polypoidal choroidal vasculopathy). The FDA recently granted clearance for SMD to conduct a pivotal study for PCV, marking a significant milestone. This clearance positions SMD to become the first FDA-approved treatment for the PCV indication, with the radiotherapy aiming to enter the $15 billion injection market (anti-VEGF monotherapy). Established in 2008 and headquartered in the United States, Salutaris Medical Devices presents an innovative approach to addressing unmet needs in eye disease treatment. The $144.48KVenture Round investment at 15 February 2018 bolstered the company's efforts, signaling investor interest in its pioneering radiotherapeutic solutions for challenging eye diseases.

Taxonomy: Radiotherapy, BetaCurve, Ophthalmology, Eye Diseases, Wet-AMD, Strontium-90, PCV, FDA Approval, Clinical-stage, Precision Treatment, Healthcare Innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 15 Feb 2018
Venture Round •••••• - 25 Mar 2015
Debt Financing •••••• - 17 Jul 2014
Debt Financing •••••• - 05 Sep 2012
Debt Financing •••••• - 14 Oct 2011

View All 7 Funding Rounds

Salutaris Medical Devices Alternatives & Competitors

Salutaris Medical Devices vs
Hemera Biosciences LLC
Hemera Biosciences LLC United States

Developing HMR59, an intravitreal gene therapy, to preserve vision in eyes with dry age-related macu...

Series Unknown
1 employees
Biotechnology
Salutaris Medical Devices vs
Samsara Vision
Samsara Vision United States

Focused on bringing vision and freedom back to late-stage AMD patients

40 employees
Manufacturing, Marketing
Salutaris Medical Devices vs
Notal Vision
Notal Vision United States

A digital healthcare provider offering remote monitoring services to support physicians' AMD patient...

Series D
86 employees
Health Care, Medical Devices

FAQ About Salutaris Medical Devices

Pioneering breakthroughs in treating eye diseases with precision radiotherapy.
Salutaris Medical Devices was founded in 2008.
Salutaris Medical Devices is headquartered in Tucson, United States.
Salutaris Medical Devices operates in the following industries: Biotechnology, Health Care, Medical Devices.
Salutaris Medical Devices has approximately 3 employees.
Salutaris Medical Devices has completed 7 funding rounds, raising a total of $5.87M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Salutaris Medical Devices include Hemera Biosciences LLC, Samsara Vision, Notal Vision, VISION CARE CENTER LIMITED, Replenish, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Salutaris Medical Devices and Hemera Biosciences LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Salutaris Medical Devices and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes